TGTX
Tg Therapeutics Inc Earnings
$30.1
Earnings Summary
Revenue | $192.57Mn |
Net Profits | $23.04Mn |
Net Profit Margins | 11.96% |
Tg Therapeutics Inc’s revenue jumped 78% since last year same period to $192.57Mn in the Q4 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated 19.09% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit fell -1.26% since last year same period to $23.04Mn in the Q4 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated -94.11% fall in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin fell -44.53% since last year same period to 11.96% in the Q4 2025. On a quarterly growth basis, Tg Therapeutics Inc has generated -95.05% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.33 |
EPS Estimate Current Year | 0.33 |
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.33 - a 48.68% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.33.
Key Ratios
Earning Per Share (EPS) | 0.14 |
Tg Therapeutics Inc’s earning per share (EPS) fell -6.67% since last year same period to 0.14 in the Q4 2025. This indicates that the Tg Therapeutics Inc has generated -6.67% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-05 | 0.22 | 2.43 | 1004.55% |
2026-02-27 | 0.33 | 0.14 | -57.2% |
2025-08-08 | 0.19 | 0.17 | -10.53% |
2025-05-09 | 0.17 | 0.03 | -82.76% |
